CORCEPT THERAPEUTICS INC (CORT) /
The cash flow of CORCEPT THERAPEUTICS INC over the past 10 years
Chart CORCEPT THERAPEUTICS INC: operating cash flow, capital expenditures, free cash flow, fiscal 2016–2025 Open the chart →In fiscal 2025, the latest fiscal year on file, CORCEPT THERAPEUTICS INC's operating cash flow was $142M and its capital expenditures $211K, leaving free cash flow of $141.78M. Free cash flow was above zero in all 10 years shown. It ranged from $18.2M in fiscal 2016 to $196.12M in fiscal 2024. Capital expenditures were highest in fiscal 2024, at $2.17M.
Year by year
| Fiscal year | Operating cash flow | Capital expenditures | Free cash flow* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $142M | $211K | $141.78M |
| 2024ended Dec 31, 2024 | $198.29M | $2.17M | $196.12M |
| 2023ended Dec 31, 2023 | $126.68M | $139K | $126.54M |
| 2022ended Dec 31, 2022 | $120.32M | $413K | $119.91M |
| 2021ended Dec 31, 2021 | $167.89M | $469K | $167.42M |
| 2020ended Dec 31, 2020 | $151.97M | $1.24M | $150.73M |
| 2019ended Dec 31, 2019 | $136.12M | $1.09M | $135.03M |
| 2018ended Dec 31, 2018 | $115.67M | $298K | $115.37M |
| 2017ended Dec 31, 2017 | $60.94M | $419K | $60.52M |
| 2016ended Dec 31, 2016 | $18.39M | $194K | $18.2M |
Fiscal years as CORCEPT THERAPEUTICS INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on CORCEPT THERAPEUTICS INC
- The revenue of CORCEPT THERAPEUTICS INC
- The profitability of CORCEPT THERAPEUTICS INC
- The debt of CORCEPT THERAPEUTICS INC
- All of CORCEPT THERAPEUTICS INC's financials, charted
Companies of a similar size
- BPOPPOPULAR, INC.
- AAAlcoa Corp
- AHRAmerican Healthcare REIT, Inc.
- TTCTHE TORO COMPANY
- AGNCAGNC INVESTMENT CORP.
Not investment advice. This page shows what CORCEPT THERAPEUTICS INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.